A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

Background: miR-346 was identified as an activator of Androgen Receptor (AR) signalling that associates with DNA damage response (DDR)-linked transcripts in prostate cancer (PC). We sought to delineate the impact of miR-346 on DNA damage, and its potential as a therapeutic agent. Methods: RNA-IP, RN...

Full description

Bibliographic Details
Main Authors: Bevan, C.L (Author), Bogdan, D. (Author), Bristow, R. (Author), Bryant, R.J (Author), Constantin, T.A (Author), Cyran, O.W (Author), de Bono, J. (Author), Deng, L. (Author), Dobbs, F.M (Author), Feng, F.Y (Author), Figueiredo, I. (Author), Fletcher, C.E (Author), Gurel, B. (Author), Hester, J. (Author), Issa, F. (Author), Knudsen, K. (Author), Kudo, H. (Author), Leach, D.A (Author), Liu, Y. (Author), Lorentzen, M.P.G.S (Author), Mills, I.G (Author), Neeb, A. (Author), Orafidiya, F. (Author), Parkes, E. (Author), Pereira, R.R (Author), Philippou, Y. (Author), Reed, S.H (Author), Varela-Carver, A. (Author), Yuan, W. (Author), Zhao, S.G (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher